// App-Quantinova.ai

2887 : Bispecific antibody drug conjugates targeting CD7 and CD33 for the treatment of acute myeloid leukemia

Researchers

Presenter

  • Richard Bethell

Principal Investigators

  • Cath Eberlein

  • Victoria Pollard

  • Theonie Georgiou

  • George Orphanides

  • Lorraine Mooney

  • Jane Kendrew

  • Tiffany Daniels

Medical Centers

  • BiVictriX Therapeutics Ltd., Nether Alderley, United Kingdom

  • Alderley Park Ltd., Nether Alderley, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Apparent diffusion coefficient

Drug/Treatment

  • Gemtuzumab ozogamicin

  • citrulline

  • Cytarabine liposomal

  • Cysteine Hydrochloride

  • monomethyl auristatin E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved